发明名称 PHARMACEUTICAL COMPOSITION HAVING REDUCED TENDENCY FOR DRUG CRYSTALLIZATION
摘要 <p>An orally deliverable pharmaceutical composition is provided comprising a drug of low water solubility, a solvent liquid that comprises at least one pharmaceutically acceptable solvent, and a turbidity-decreasing polymer, wherein (a) a substantial portion, for example at least about 15 % by weight, of the drug is in dissolved or solubilized form in the solvent liquid, and (b) the polymer is present in an amount sufficient to substantially inhibit crystallization and/or precipitation of the drug in simulated gastric fluid.</p>
申请公布号 WO2002056878(A2) 申请公布日期 2002.07.25
申请号 US2002000971 申请日期 2002.01.15
申请人 发明人
分类号 主分类号
代理机构 代理人
主权项
地址